NCT07181499 2025-09-30Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKIBetta Pharmaceuticals Co., Ltd.Phase 2 Recruiting28 enrolled
NCT06754644 2025-06-10A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLCQilu Pharmaceutical Co., Ltd.Phase 3 Recruiting808 enrolled